Impact of a Physical Activity Program on the Mental Health of Medical Students.
Launched by RESEARCH ON HEALTHCARE PERFORMANCE LAB U1290 · Feb 5, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The SANTE project is a clinical trial that aims to understand how a physical activity program can help improve the mental health of medical students at the University of Lyon 1. Many medical students face high levels of stress and often feel isolated, which can lead to mental health issues like depression and anxiety. The goal of this study is to see if being more active can make a positive difference in their mental well-being.
To participate in this study, you must be a second or third-year medical student at the Lyon East or Lyon South Faculty of Medicine during the 2024-2025 academic years. There are no specific exclusion criteria, meaning anyone who meets the age and study requirements can join. Participants can expect to engage in a structured physical activity program designed to help them feel better both physically and mentally. The study is currently not yet recruiting, but it represents a hopeful step towards supporting the health of medical students.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a 2th-year or a 3th-year medical student at the Faculty of Medicine Lyon East and Lyon South during the academic years 2024-2025.
- • Having read the information note.
- • Having signed the written consent.
- Exclusion Criteria:
- • No exclusion criteria will be applied.
About Research On Healthcare Performance Lab U1290
The Research on Healthcare Performance Lab U1290 is a dedicated clinical trial sponsor focused on advancing healthcare outcomes through rigorous research and innovative methodologies. With a commitment to improving patient care, the lab conducts comprehensive studies that evaluate healthcare performance metrics, treatment efficacy, and patient satisfaction. By collaborating with healthcare institutions and leveraging cutting-edge technologies, U1290 aims to generate actionable insights that drive evidence-based practices and enhance the overall quality of care in diverse medical settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Trial Officials
Sophie Schlatter, Dr.
Principal Investigator
RESHAPE U1290 INSERM UCBL-LYON 1 Rockfeller, Lyon France.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported